Multiple Assemblies exist for SMTL entry 3r4n
Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide; X-RAY DIFFRACTION 2.00 Å

	SMTL ID 3r4n.1 Ligands 4-[2-chloro-6-(4,4,4-trifluorobutoxy)phenyl]-6-methylpyrimidin-2-amine Polypeptides Heat shock protein HSP 90-alpha Oligo-state monomer
	SMTL ID 3r4n.2 Ligands 4-[2-chloro-6-(4,4,4-trifluorobutoxy)phenyl]-6-methylpyrimidin-2-amine Polypeptides Heat shock protein HSP 90-alpha Oligo-state monomer
	SMTL ID 3r4n.3 Ligands 4-[2-chloro-6-(4,4,4-trifluorobutoxy)phenyl]-6-methylpyrimidin-2-amine Polypeptides Heat shock protein HSP 90-alpha Oligo-state homo-dimer